Insmed (NASDAQ:INSM) PT Raised to $67.00
Insmed (NASDAQ:INSM – Free Report) had its price target boosted by TD Cowen from $45.00 to $67.00 in a report released on Wednesday, Benzinga reports. The firm currently has a buy rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently weighed in on INSM. Guggenheim raised their price objective on […]
More Stories
NB Bancorp (NASDAQ:NBBK) and Affinity Bancshares (NASDAQ:AFBI) Head-To-Head Survey
NB Bancorp (NASDAQ:NBBK – Get Free Report) and Affinity Bancshares (NASDAQ:AFBI – Get Free Report) are both small-cap finance companies,...
Mother Iggy (MOTHER) Reaches Self Reported Market Cap of $24.00 Million
Mother Iggy (MOTHER) traded 7.6% lower against the U.S. dollar during the 24-hour period ending at 12:00 PM ET on...
World Mobile Token Price Tops $0.38 on Exchanges (WMT)
World Mobile Token (WMT) traded down 9.3% against the U.S. dollar during the 24 hour period ending at 12:00 PM...
UMA (UMA) Trading Down 7.2% Over Last Week
UMA (UMA) traded up 0.4% against the U.S. dollar during the 1-day period ending at 12:00 PM ET on January...
Chellitcoin (CHLT) Hits One Day Trading Volume of $10.49
Chellitcoin (CHLT) traded flat against the dollar during the 24 hour period ending at 12:00 PM E.T. on January 9th....
Adobe (NASDAQ:ADBE) Trading Down 0.7% – What’s Next?
Adobe Inc. (NASDAQ:ADBE – Get Free Report) shares fell 0.7% during mid-day trading on Thursday . The stock traded as...